Across the country, state lawmakers are considering ways to address the risks posed by the explosion of power-hungry data ...

In this week’s Crypto Long & Short Newsletter, Ruchir Gupta writes on how we’re moving toward a true fixed-income market for ...

Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...

Lens AI, powered by the proprietary HIFT system, advanced functional adjacency capabilities and identified a single conserved functional feature across 2,000+ influenza sequences. Dengue Pipeline -- ...

The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective ...

Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...

Third-party apps, aftermarket parts, and hidden settings can make your Peloton experience so much better.

Dividend Declaration -- The Board declared a $0.42 per share dividend, representing a 9.8% annualized rate on ending book ...

Total revenue -- $41.3 million in fiscal Q4 (period ended Dec. 31, 2025), with $25.3 million from Energy Industrial and $16.1 ...

Good afternoon, and welcome to Arthur J. Gallagher & Company's quarterly investor meeting with management. [Operator Instructions] Today's call is being recorded. If you have any objections, you may ...

Q4 2025 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsKyle Pilkington - Chief Legal OfficerQichao Hu - ...

Thank you, Jonathan, and thanks to all of you for joining us this afternoon to review Definitive Healthcare Corp.'s fourth ...